Renovaro (RENB) Stock Chart & Stock Price History → Trump convicted... now what? (From Stansberry Research) (Ad) Free RENB Stock Alerts Notice: Trading of Renovaro halted at 09:51 AM EST due to "LULD pause". $1.74 +0.45 (+34.88%) (As of 10:20 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Renovaro Stock Price Performance5 Day Performance-7.93%1 Month Performance+15.70%3 Month Performance-58.23%6 Month Performance-62.54%Year-To-Date Performance-58.76% Receive RENB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Renovaro and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", RENB Stock Chart for Monday, June, 10, 2024 RENB Chart by TradingView Renovaro Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$1.33$1.29-3.01%$1.43$1.28157,793 shs$190.29 million06/06/2024$1.42$1.33-6.34%$1.47$1.31229,547 shs$196.18 million06/05/2024$1.45$1.42-2.07%$1.49$1.38162,717 shs$209.46 million06/04/2024$1.41$1.45+2.84%$1.49$1.32186,060 shs$213.89 million06/03/2024$1.49$1.41-5.37%$1.55$1.30245,428 shs$207.99 million05/31/2024$1.47$1.49+1.36%$1.58$1.45242,715 shs$219.79 million Get the Latest News and Ratings for RENB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renovaro and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$1.47$1.47$1.57$1.36380,273 shs$216.84 million05/29/2024$1.47$1.47$1.50$1.32233,625 shs$216.84 million05/28/2024$1.42$1.47+3.52%$1.75$1.451.17 million shs$216.83 million05/27/2024$1.42$1.42$1.49$1.201.14 million shs$209.46 million05/24/2024$1.32$1.42+7.58%$1.49$1.201.14 million shs$209.46 million05/23/2024$0.94$1.32+40.43%$1.61$1.004.92 million shs$194.71 million05/22/2024$0.96$0.94-2.08%$1.00$0.9369,746 shs$138.66 million05/21/2024$0.97$0.96-1.03%$1.08$0.87153,667 shs$141.61 million05/20/2024$0.97$0.97$1.16$0.94320,433 shs$143.09 million05/17/2024$0.92$0.97+5.75%$1.00$0.90153,451 shs$139.36 million05/16/2024$0.95$0.92-3.17%$1.17$0.82359,562 shs$131.79 million05/15/2024$1.04$0.95-8.91%$1.13$0.90236,904 shs$136.10 million05/14/2024$1.16$1.04-10.34%$1.17$1.01258,467 shs$149.42 million05/13/2024$1.13$1.16+2.65%$1.28$1.10235,511 shs$166.66 million05/10/2024$1.20$1.13-5.83%$1.26$1.13189,529 shs$162.35 million05/09/2024$1.46$1.20-17.81%$1.48$1.18206,632 shs$172.40 million05/08/2024$1.49$1.46-2.01%$1.55$1.32269,281 shs$209.76 million05/07/2024$1.48$1.49+0.68%$1.52$1.44241,582 shs$214.07 million05/06/2024$1.50$1.48-1.33%$1.55$1.48177,717 shs$212.63 million05/03/2024$1.49$1.50+0.67%$1.58$1.45307,480 shs$214.07 million05/02/2024$1.47$1.49+1.36%$1.58$1.42217,116 shs$214.07 million05/01/2024$1.58$1.47-6.96%$1.61$1.45451,182 shs$211.20 million04/30/2024$1.56$1.58+1.28%$1.84$1.501.00 million shs$227.00 million04/29/2024$1.53$1.56+1.96%$1.62$1.24439,479 shs$224.13 million04/26/2024$1.70$1.53-10.00%$2.10$1.501.04 million shs$219.82 million04/25/2024$1.97$1.70-13.71%$1.99$1.56427,977 shs$244.24 million04/24/2024$2.02$1.97-2.48%$2.09$1.89206,935 shs$283.03 million04/23/2024$2.15$2.02-6.05%$2.18$1.93292,609 shs$290.21 million04/22/2024$2.17$2.15-0.92%$2.20$2.11110,931 shs$308.89 million04/19/2024$2.30$2.17-5.65%$2.28$1.98207,910 shs$144.74 million04/18/2024$2.22$2.30+3.60%$2.38$2.13127,476 shs$153.41 million04/17/2024$2.42$2.22-8.26%$2.45$2.19157,145 shs$148.07 million04/16/2024$2.45$2.42-1.22%$2.70$2.34200,427 shs$161.41 million04/15/2024$2.36$2.45+3.81%$2.62$2.28424,118 shs$163.42 millionNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY04/12/2024$2.45$2.36-3.67%$2.52$2.26238,740 shs$157.41 million04/11/2024$2.48$2.45-1.21%$2.61$2.38311,926 shs$163.42 million04/10/2024$2.79$2.48-11.11%$2.84$2.43212,540 shs$165.42 million04/09/2024$2.85$2.79-2.11%$2.97$2.71131,571 shs$186.09 million04/08/2024$2.76$2.85+3.26%$2.93$2.65165,117 shs$190.10 million04/05/2024$2.79$2.76-1.08%$2.94$2.59248,697 shs$184.09 million04/04/2024$2.77$2.79+0.72%$2.90$2.7296,022 shs$186.09 million04/03/2024$2.82$2.77-1.77%$2.88$2.7455,280 shs$184.76 million04/02/2024$3.00$2.82-6.00%$3.00$2.75110,403 shs$188.09 million04/01/2024$2.65$3.00+13.21%$3.05$2.61151,060 shs$200.10 million03/29/2024$2.65$2.65$2.79$2.62130,729 shs$176.76 million03/28/2024$2.79$2.65-5.02%$2.79$2.62131,077 shs$176.76 million03/27/2024$2.92$2.79-4.45%$3.00$2.76243,132 shs$186.09 million03/26/2024$2.91$2.92+0.34%$3.04$2.84107,819 shs$194.76 million03/25/2024$3.23$2.91-9.91%$3.13$2.80311,024 shs$194.09 million03/22/2024$2.94$3.23+9.86%$3.24$2.85117,150 shs$215.44 million03/21/2024$2.91$2.94+1.03%$2.94$2.77229,150 shs$196.10 million03/20/2024$3.20$2.91-9.06%$3.17$2.79206,628 shs$194.09 million03/19/2024$3.00$3.20+6.67%$3.20$2.801.03 million shs$213.44 million03/18/2024$3.17$3.00-5.36%$3.13$2.871.10 million shs$200.10 million03/15/2024$3.13$3.17+1.28%$3.25$2.971.49 million shs$211.43 million03/14/2024$3.01$3.13+3.99%$3.17$2.83882,750 shs$208.77 million03/13/2024$3.11$3.01-3.22%$3.15$2.801.04 million shs$200.77 million03/12/2024$2.98$3.11+4.36%$3.21$2.93264,647 shs$207.44 million03/11/2024$3.13$2.98-4.79%$3.28$2.96359,289 shs$198.76 million Related Companies: Aurinia Pharmaceuticals Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart Tango Therapeutics Stock Price Chart Olema Pharmaceuticals Stock Price Chart Evolus Stock Price Chart Wave Life Sciences Stock Price Chart Phibro Animal Health Stock Price Chart Praxis Precision Medicines Stock Price Chart Nuvation Bio Stock Price Chart Longboard Pharmaceuticals Stock Price Chart Receive RENB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renovaro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RENB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Renovaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.